Supernus Pharmaceuticals, Inc.
DE ˙ DB ˙ US8684591089
37,80 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:S49 / Supernus Pharmaceuticals, Inc.
InstitutionComerica Bank
Latest Disclosed Ownership36,125 shares
Latest Disclosed Value $ 1,795,400
Comerica Bank reports 1.52% decrease in ownership of S49 / Supernus Pharmaceuticals, Inc.

On January 29, 2026 - Comerica Bank filed a 13F-HR form disclosing ownership of 36,125 shares of Supernus Pharmaceuticals, Inc. (DE:S49) valued at $1,560,600 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 36,683 shares of Supernus Pharmaceuticals, Inc.. This represents a change in shares of -1.52% during the quarter. The current value of the position is $1,365,525 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 36,125 -558 -1.52 1,795 2.40 0.0072
2025-11-14 2025-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 36,683 -2,744 -6.96 1,753 41.14 0.0066
2025-08-14 2025-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 39,427 2,853 7.80 1,243 3.76 0.0048
2025-05-14 2025-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 36,574 -974 -2.59 1,198 -11.79 0.0050
2025-02-14 2024-12-31 13F/A-1 SUPERNUS PHARMACEUTICALS COM 868459108 37,548 15,585 70.96 1,358 98.39 0.0055
2025-02-14 2024-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 37,548 15,585 1,358 0.0045
2024-11-14 2024-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 21,963 -655 -2.90 685 13.06 0.0027
2024-08-15 2024-06-30 13F SUPERNUS PHARMACEUTICALS COMMON 868459108 22,618 -2,622 -10.39 605 -29.65 0.0025
2024-05-16 2024-03-31 13F SUPERNUS PHARMACEUTICALS COMMON 868459108 25,240 -2,380 -8.62 861 7.63 0.0037
2024-02-14 2023-12-31 13F SUPERNUS PHARMACEUTICALS COMMON 868459108 27,620 -4 -0.01 799 4.99 0.0037
2023-11-21 2023-09-30 13F SUPERNUS PHARMACEUTICALS COMMON 868459108 27,624 27,624 762 0.0040
2023-08-22 2023-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 0 -32,528 -100.00 0 -100.00
2023-01-26 2022-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 32,528 -8,925 -21.53 1 -99.93 0.0101
2022-10-28 2022-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 41,453 -4,485 -9.76 1,405 2.11 0.0118
2022-08-02 2022-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 45,938 -35 -0.08 1,376 0.95 0.0113
2022-04-27 2022-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 45,973 -155 -0.34 1,363 -0.51 0.0099
2022-02-18 2021-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 46,128 -2,528 -5.20 1,370 -5.52 0.0101
2021-11-22 2021-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 48,656 -912 -1.84 1,450 24.25 0.0087
2021-08-26 2021-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 49,568 -3,898 -7.29 1,167 -30.49 0.0070
2021-04-28 2021-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 53,466 -1,890 -3.41 1,679 1.33 0.0100
2021-01-28 2020-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 55,356 296 0.54 1,657 49.82 0.0105
2020-10-30 2020-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 55,060 -165 -0.30 1,106 -15.12 0.0080
2020-07-31 2020-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 55,225 4,179 8.19 1,303 34.61 0.0100
2020-05-01 2020-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 51,046 1,857 3.78 968 -16.05 0.0089
2020-02-07 2019-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 49,189 -39 -0.08 1,153 -11.92 0.0087
2019-10-31 2019-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 49,228 -257 -0.52 1,309 -17.05 0.0103
2019-08-02 2019-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 49,485 -2,668 -5.12 1,578 -21.65 0.0126
2019-05-02 2019-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 52,153 1,436 2.83 2,014 8.05 0.0163
2019-02-06 2018-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 50,717 169 0.33 1,864 -22.11 0.0158
2018-11-01 2018-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 50,548 -4,082 -7.47 2,393 -18.19 0.0193
2018-08-01 2018-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 54,630 603 1.12 2,925 10.84 0.0205
2018-05-01 2018-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 54,027 1,261 2.39 2,639 15.90 0.0189
2018-02-02 2017-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 52,766 -952 -1.77 2,277 3.64 0.0152
2017-11-06 2017-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 53,718 755 1.43 2,197 -4.64 0.0159
2017-08-03 2017-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 52,963 -2,696 -4.84 2,304 24.68 0.0172
2017-05-03 2017-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 55,659 2,828 5.35 1,848 39.37 0.0140
2017-02-08 2016-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 52,831 17,657 50.20 1,326 62.70 0.0105
2016-08-11 2016-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 35,174 413 1.19 815 43.74 0.0070
2016-05-11 2016-03-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 34,761 293 0.85 567 40.69 0.0051
2016-02-05 2015-12-31 13F SUPERNUS PHARMACEUTICALS COM 868459108 34,468 194 0.57 403 -16.22 0.0040
2015-11-12 2015-09-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 34,274 -23,552 -40.73 481 -51.02 0.0046
2015-08-13 2015-06-30 13F SUPERNUS PHARMACEUTICALS COM 868459108 57,826 57,826 982 0.0042
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.